Literature DB >> 12209650

CD4+CD25+ T cells as immunoregulatory T cells in vitro.

Jian-Guo Chai1, Julia Y S Tsang, Robert Lechler, Elizabeth Simpson, Julian Dyson, Diane Scott.   

Abstract

We have further characterized the in vitro phenotype and function of anergic and suppressive CD4(+)25(+) T cells. Following TCR ligation, DO.11.10 CD4(+)25(+) T cells suppress the activation of OT-1 CD8(+)25(-) T cells in an antigen nonspecific manner. Although suppression was seen when using a mixture of APC from both parental strains, it was very much more marked when using F1 APC. APC pretreated with, and then separated from CD4(+)25(+) T cells did not have diminished T cell costimulatory function, suggesting that APC are not the direct targets of CD4(+)25(+) T cell regulation. CTLA-4 blockade failed to abrogate suppression by CD4(+)25(+) T cells in mixing experiments. Although CD4(+)25(+) T cells failed to respond following cross-linking of TCR, they could be induced to proliferate following the addition of exogenous IL-2, allowing the generation of a T cell line from CD4(+)25(+) T cells. After the first in vitro restimulation, CD4(+)25(+) T cells were still anergic and suppressive following TCR engagement. However, after three rounds of restimulation, their anergic and suppressive status was abrogated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209650     DOI: 10.1002/1521-4141(200208)32:8<2365::AID-IMMU2365>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 2.  Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases.

Authors:  Xiaohui Zhou; Ning Kong; Hejian Zou; David Brand; Xianpei Li; Zhongmin Liu; Song Guo Zheng
Journal:  Autoimmunity       Date:  2010-07-29       Impact factor: 2.815

Review 3.  Checkpoint blockade in cancer immunotherapy.

Authors:  Alan J Korman; Karl S Peggs; James P Allison
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 4.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.

Authors:  Cecilia Oderup; Lukas Cederbom; Anna Makowska; Corrado M Cilio; Fredrik Ivars
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

6.  Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.

Authors:  Ning Kong; Qin Lan; Maogen Chen; Julie Wang; Wei Shi; David A Horwitz; Valerie Quesniaux; Bernhard Ryffel; Zhongmin Liu; David Brand; Hejian Zou; Song Guo Zheng
Journal:  Arthritis Rheum       Date:  2012-08

7.  Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.

Authors:  Filiberto Cedeno-Laurent; Steven R Barthel; Matthew J Opperman; David M Lee; Rachael A Clark; Charles J Dimitroff
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

8.  CD4+CD25+ regulatory T cells have divergent effects on intestinal inflammation in IL-10 gene-deficient mice.

Authors:  Beate C Sydora; Sarah M MacFarlane; Michele M Tavernini; Jason S G Doyle; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism.

Authors:  Anping Xu; Ya Liu; Weiqian Chen; Julie Wang; Youqiu Xue; Feng Huang; Liming Rong; Jin Lin; Dahai Liu; Mei Yan; Quan-Zhen Li; Bin Li; Jianxun Song; Nancy Olsen; Song Guo Zheng
Journal:  J Immunol       Date:  2016-03-21       Impact factor: 5.422

Review 10.  Treg and CTLA-4: two intertwining pathways to immune tolerance.

Authors:  Lucy S K Walker
Journal:  J Autoimmun       Date:  2013-07-10       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.